title: Analysis of subcutaneous and visceral fat after gastric balloon treatment.
abstract: OBJECTIVE
  This project is a continuation of a larger project entitled "Treatment with intragastric balloon (IGB) in patients with overweight and obesity in Recife" developed by Professor Dr. Gustavo Lopes de Carvalho. It is a project studying the effectiveness of treatment with IGB evaluating the loss of weight and body mass index and its impact on blood pressure, blood glucose, triglycerides, total cholesterol and fractions. It also assesses the lifestyle of patients studying whether treatment with IGB interferes in smoking, alcohol consumption, eating habits and physical exercises performed by patients. The present study added a larger project, the separate evaluation of the different types of abdominal fat-visceral fat and subcutaneous cell tissue fat - and was conducted to discover which of the 2 types of fat undergoes the greater reduction after IGB treatment. To measure these 2 types of fat, we used the ultrasonography technique, because it has been shown to be accurate and noninvasive.
  
  
  METHODS
  Twenty-five patients were evaluated before and after 6 months of IGB treatment.
  
  
  RESULTS
  The patients' ages ranged from 20 to 61 years, with 60% being 40 years of age or older. The majority (72%) were women. All variables (weight, body mass index [BMI], VF, and SCTF) showed a significant reduction (P < .05) in mean values after treatment. The difference was highest in the SCTF (17.5%) and ranged from an 11.4% to an 11.6% reduction in all other variables. The average loss of SCTF was highest among the patients who had lost up to 10.0% of their initial weight (19.2% for the ≤10.0% group vs 15.9% for the >10.0% group); however, the difference was not significant (P = .66). The average loss of VF was higher in the subgroup of patients who had lost >10.0% of their initial weight (16.2% vs 6.3%; P = .003). The Pearson correlation between the reductions in SCTF vs VF was negative, low, and nonsignificant (-0.17; P = .41).
  
  
  CONCLUSIONS
  After 6 months of IGB treatment, there was no significant difference between the reduction in abdominal SCTF and VF, but the results signify a possible correlation between the percentage of body weight loss and the type of abdominal fat reduced, as the impact on the VF was higher when the patients lost >10.0% of their initial weight.
authors.affiliation: University of Pernambuco, Pernambuco, Brasil.
authors.forename: Luana C
authors.initials: LC
authors.lastname: Cabral
authors.affiliation: University of Pernambuco, Pernambuco, Brasil.
authors.forename: Gustavo L
authors.initials: GL
authors.lastname: de Carvalho
authors.affiliation: University of Pernambuco, Pernambuco, Brasil.
authors.forename: Rayssa A B
authors.initials: RA
authors.lastname: de Melo
authors.affiliation: Instituto de Medicina Integrado Professor Fernando Figueira, Pernambuco, Brasil.
authors.forename: Fernanda M
authors.initials: FM
authors.lastname: de Moura
authors.affiliation: University of Pernambuco, Pernambuco, Brasil.
authors.forename: Ana Paula D L
authors.initials: AP
authors.lastname: Leite
mesh_terms: D050153:Abdominal Fat / Q000000981:diagnostic imaging*; D000328:Adult; D015992:Body Mass Index; D005260:Female; D005500:Follow-Up Studies; D015905:Gastric Balloon; D006801:Humans; D008297:Male; D008875:Middle Aged; D050507:Subcutaneous Fat, Abdominal / Q000000981:diagnostic imaging*; D014463:Ultrasonography; D015431:Weight Loss; D055815:Young Adult
keywords: Abdominal fat; Abdominal obesity; Abnominal ultrasonography; Intragastric balloon; Subcutaneous fat; Visceral fat